A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates

Clinical trial NCT02762123 · COMPLETED

Trial details

NCT number: NCT02762123
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2016-05-01
Primary completion: 2016-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.